|
|
amine metabolic process
|
GO:0009308 |
45 |
0.845
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.819
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.805
|
|
|
|
autonomic nervous system development
|
GO:0048483 |
43 |
0.804
|
|
|
|
regulation of ion homeostasis
|
GO:2000021 |
64 |
0.760
|
|
|
|
neuron projection guidance
|
GO:0097485 |
141 |
0.755
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.674
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.647
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.621
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.618
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.578
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.576
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.561
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.542
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.493
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.492
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.490
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.472
|
|
|
|
developmental growth involved in morphogenesis
|
GO:0060560 |
138 |
0.446
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.441
|
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.428
|
|
|
|
regulation of canonical wnt signaling pathway
|
GO:0060828 |
82 |
0.419
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.409
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.397
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.384
|
|
|
|
neuron projection extension
|
GO:1990138 |
64 |
0.384
|
|
|
|
diencephalon development
|
GO:0021536 |
63 |
0.379
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.378
|
|
|
|
gliogenesis
|
GO:0042063 |
141 |
0.365
|
|
|
|
nephron development
|
GO:0072006 |
109 |
0.363
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.362
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.354
|
|
|
|
regulation of axon extension
|
GO:0030516 |
43 |
0.349
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.346
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.345
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.342
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.341
|
|
|
|
male gonad development
|
GO:0008584 |
88 |
0.340
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.336
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.333
|
|
|
|
brain segmentation
|
GO:0035284 |
3 |
0.331
|
|
|
|
glial cell differentiation
|
GO:0010001 |
131 |
0.329
|
|
|
|
endocrine system development
|
GO:0035270 |
98 |
0.321
|
|
|
|
neuromuscular synaptic transmission
|
GO:0007274 |
16 |
0.320
|
|
|
|
cell fate specification
|
GO:0001708 |
72 |
0.317
|
|
|
|
nerve development
|
GO:0021675 |
67 |
0.316
|
|
|
|
limbic system development
|
GO:0021761 |
72 |
0.315
|
|
|
|
cranial nerve development
|
GO:0021545 |
41 |
0.315
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.309
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.309
|
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.307
|
|
|
|
axon guidance
|
GO:0007411 |
141 |
0.297
|
|
|
|
development of primary male sexual characteristics
|
GO:0046546 |
88 |
0.296
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.290
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.288
|
|
|
|
positive regulation of neuron differentiation
|
GO:0045666 |
141 |
0.286
|
|
|
|
regulation of cell morphogenesis involved in differentiation
|
GO:0010769 |
151 |
0.282
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.282
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.278
|
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
145 |
0.271
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.269
|
|
|
|
development of primary female sexual characteristics
|
GO:0046545 |
73 |
0.266
|
|
|
|
cell growth
|
GO:0016049 |
130 |
0.264
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.259
|
|
|
|
glomerulus development
|
GO:0032835 |
40 |
0.257
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.257
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.255
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.254
|
|
|
|
pallium development
|
GO:0021543 |
120 |
0.253
|
|
|
|
epithelium migration
|
GO:0090132 |
63 |
0.253
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.249
|
|
|
|
kidney epithelium development
|
GO:0072073 |
121 |
0.248
|
|
|
|
negative regulation of wnt signaling pathway
|
GO:0030178 |
73 |
0.247
|
|
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
123 |
0.247
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.245
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.244
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.235
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.232
|
|
|
|
hindbrain development
|
GO:0030902 |
128 |
0.230
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.227
|
|
|
|
bmp signaling pathway
|
GO:0030509 |
93 |
0.222
|
|
|
|
subpallium neuron fate commitment
|
GO:0060163 |
2 |
0.219
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.215
|
Mouse |
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.213
|
|
|
|
developmental cell growth
|
GO:0048588 |
84 |
0.210
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.207
|
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.206
|
|
|
|
nephron morphogenesis
|
GO:0072028 |
69 |
0.204
|
|
|
|
negative regulation of neuron projection development
|
GO:0010977 |
50 |
0.203
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.200
|
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.196
|
|
|
|
pituitary gland development
|
GO:0021983 |
38 |
0.193
|
|
|
|
positive regulation of kidney development
|
GO:0090184 |
28 |
0.191
|
|
|
|
regulation of neuron projection development
|
GO:0010975 |
169 |
0.188
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.187
|
|
|
|
regulation of renal sodium excretion
|
GO:0035813 |
3 |
0.186
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.185
|
|
|
|
negative regulation of homeostatic process
|
GO:0032845 |
71 |
0.184
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.183
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.182
|
|
|
|
stem cell proliferation
|
GO:0072089 |
117 |
0.182
|
|
|
|
positive regulation of growth
|
GO:0045927 |
104 |
0.179
|
|
|
|
branching involved in ureteric bud morphogenesis
|
GO:0001658 |
56 |
0.178
|
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.177
|
Mouse |
|
|
neural precursor cell proliferation
|
GO:0061351 |
121 |
0.175
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.173
|
|
|
|
pancreas development
|
GO:0031016 |
57 |
0.171
|
|
|
|
central nervous system neuron differentiation
|
GO:0021953 |
162 |
0.166
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.166
|
|
|
|
astrocyte fate commitment
|
GO:0060018 |
4 |
0.166
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.163
|
|
|
|
cell maturation
|
GO:0048469 |
127 |
0.162
|
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.162
|
|
|
|
nephron epithelium morphogenesis
|
GO:0072088 |
68 |
0.162
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.162
|
|
|
|
renal tubule development
|
GO:0061326 |
87 |
0.161
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.161
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.160
|
|
|
|
leukocyte migration
|
GO:0050900 |
124 |
0.157
|
|
|
|
exocrine system development
|
GO:0035272 |
45 |
0.156
|
|
|
|
tissue migration
|
GO:0090130 |
68 |
0.155
|
|
|
|
cell differentiation in spinal cord
|
GO:0021515 |
53 |
0.155
|
|
|
|
metanephros morphogenesis
|
GO:0003338 |
24 |
0.155
|
|
|
|
thyroid stimulating hormone secreting cell differentiation
|
GO:0060129 |
4 |
0.155
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.154
|
|
|
|
forebrain neuron differentiation
|
GO:0021879 |
52 |
0.154
|
|
|
|
regulation of neural precursor cell proliferation
|
GO:2000177 |
70 |
0.154
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.153
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.152
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.152
|
|
|
|
rhombomere development
|
GO:0021546 |
8 |
0.151
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.149
|
|
|
|
regulation of vasculature development
|
GO:1901342 |
88 |
0.149
|
|
|
|
mesonephric tubule morphogenesis
|
GO:0072171 |
63 |
0.149
|
|
|
|
positive regulation of neuron projection development
|
GO:0010976 |
79 |
0.149
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.148
|
|
|
|
female sex differentiation
|
GO:0046660 |
84 |
0.147
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.145
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.144
|
|
|
|
cranial nerve morphogenesis
|
GO:0021602 |
26 |
0.143
|
|
|
|
positive regulation of secretion by cell
|
GO:1903532 |
114 |
0.143
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.142
|
|
|
|
peripheral nervous system development
|
GO:0007422 |
53 |
0.141
|
|
|
|
ureteric bud morphogenesis
|
GO:0060675 |
62 |
0.139
|
|
|
|
sequestering of metal ion
|
GO:0051238 |
19 |
0.138
|
|
|
|
organelle localization
|
GO:0051640 |
179 |
0.138
|
|
|
|
spinal cord development
|
GO:0021510 |
81 |
0.137
|
|
|
|
mesonephric epithelium development
|
GO:0072163 |
94 |
0.137
|
|
|
|
mitral valve morphogenesis
|
GO:0003183 |
4 |
0.137
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.136
|
|
|
|
epithelial cell migration
|
GO:0010631 |
63 |
0.136
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.135
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.134
|
|
|
|
positive regulation of cell projection organization
|
GO:0031346 |
95 |
0.134
|
|
|
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.133
|
|
|
|
male sex differentiation
|
GO:0046661 |
109 |
0.132
|
|
|
|
regulation of map kinase activity
|
GO:0043405 |
120 |
0.132
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.132
|
|
|
|
neuroblast proliferation
|
GO:0007405 |
49 |
0.131
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.131
|
|
|
|
multicellular organismal response to stress
|
GO:0033555 |
62 |
0.130
|
|
|
|
endothelial cell migration
|
GO:0043542 |
44 |
0.129
|
|
|
|
metanephric nephron morphogenesis
|
GO:0072273 |
19 |
0.127
|
|
|
|
regulation of kidney development
|
GO:0090183 |
40 |
0.127
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.126
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.125
|
|
|
|
negative regulation of mapk cascade
|
GO:0043409 |
65 |
0.125
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.125
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.125
|
|
|
|
central nervous system segmentation
|
GO:0035283 |
3 |
0.124
|
|
|
|
renal tubule morphogenesis
|
GO:0061333 |
72 |
0.123
|
|
|
|
tube formation
|
GO:0035148 |
140 |
0.122
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.121
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.121
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.121
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.121
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.121
|
|
|
|
regulation of ras protein signal transduction
|
GO:0046578 |
114 |
0.120
|
|
|
|
positive regulation of synaptic plasticity
|
GO:0031915 |
4 |
0.120
|
|
|
|
columnar cuboidal epithelial cell differentiation
|
GO:0002065 |
82 |
0.120
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.120
|
Mouse |
|
|
positive regulation of cell growth
|
GO:0030307 |
33 |
0.117
|
|
|
|
hematopoietic stem cell differentiation
|
GO:0060218 |
8 |
0.117
|
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.117
|
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
147 |
0.117
|
|
|
|
metanephros development
|
GO:0001656 |
79 |
0.116
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.116
|
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
138 |
0.116
|
|
|
|
cell chemotaxis
|
GO:0060326 |
81 |
0.116
|
|
|
|
nephron tubule development
|
GO:0072080 |
84 |
0.115
|
|
|
|
dendrite development
|
GO:0016358 |
115 |
0.115
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.114
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.114
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.113
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.113
|
|
|
|
gonad development
|
GO:0008406 |
141 |
0.113
|
|
|
|
epithelial cell morphogenesis
|
GO:0003382 |
41 |
0.111
|
|
|
|
cartilage development
|
GO:0051216 |
140 |
0.110
|
|
|
|
regulation of nucleotide catabolic process
|
GO:0030811 |
122 |
0.110
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.109
|
|
|
|
inner ear morphogenesis
|
GO:0042472 |
101 |
0.109
|
|
|
|
circadian rhythm
|
GO:0007623 |
114 |
0.108
|
|
|
|
negative regulation of vasculature development
|
GO:1901343 |
26 |
0.105
|
|
|
|
t cell differentiation
|
GO:0030217 |
174 |
0.105
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.104
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.103
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.103
|
|
|
|
regulation of transcription from rna polymerase ii promoter involved in ventral spinal cord interneuron specification
|
GO:0021913 |
4 |
0.102
|
|
|
|
metanephric nephron development
|
GO:0072210 |
34 |
0.102
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
126 |
0.102
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.100
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.099
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.098
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.097
|
|
|
|
positive regulation of cell motility
|
GO:2000147 |
116 |
0.095
|
|
|
|
endocardial cushion to mesenchymal transition involved in heart valve formation
|
GO:0003199 |
4 |
0.095
|
|
|
|
segmentation
|
GO:0035282 |
93 |
0.095
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.095
|
|
|
|
positive regulation of auditory receptor cell differentiation
|
GO:0045609 |
1 |
0.094
|
|
|
|
regulation of cellular component size
|
GO:0032535 |
121 |
0.094
|
|
|
|
positive regulation of lymphocyte activation
|
GO:0051251 |
140 |
0.094
|
|
|
|
glial cell fate commitment
|
GO:0021781 |
14 |
0.093
|
|
|
|
positive regulation of stem cell proliferation
|
GO:2000648 |
59 |
0.091
|
|
|
|
skeletal muscle cell differentiation
|
GO:0035914 |
66 |
0.091
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.091
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.091
|
|
|
|
cardiac muscle cell differentiation
|
GO:0055007 |
69 |
0.091
|
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.090
|
|
|
|
positive regulation of cytosolic calcium ion concentration
|
GO:0007204 |
65 |
0.090
|
|
|
|
response to oxygen levels
|
GO:0070482 |
62 |
0.089
|
|
|
|
visceral serous pericardium development
|
GO:0061032 |
2 |
0.089
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.088
|
|
|
|
response to peptide
|
GO:1901652 |
136 |
0.088
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.088
|
|
|
|
neuroepithelial cell differentiation
|
GO:0060563 |
37 |
0.088
|
|
|
|
regulation of myeloid cell differentiation
|
GO:0045637 |
96 |
0.087
|
|
|
|
forebrain generation of neurons
|
GO:0021872 |
63 |
0.087
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.087
|
|
|
|
neuron migration
|
GO:0001764 |
122 |
0.087
|
|
|
|
metanephric glomerulus development
|
GO:0072224 |
13 |
0.087
|
|
|
|
brain morphogenesis
|
GO:0048854 |
32 |
0.086
|
|
|
|
negative regulation of map kinase activity
|
GO:0043407 |
34 |
0.085
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.085
|
|
|
|
chondrocyte differentiation
|
GO:0002062 |
72 |
0.085
|
|
|
|
cytosolic calcium ion homeostasis
|
GO:0051480 |
70 |
0.084
|
|
|
|
synapse organization
|
GO:0050808 |
125 |
0.084
|
|
|
|
enteric nervous system development
|
GO:0048484 |
11 |
0.084
|
|
|
|
regulation of ras gtpase activity
|
GO:0032318 |
88 |
0.084
|
|
|
|
forebrain morphogenesis
|
GO:0048853 |
17 |
0.083
|
|
|
|
ear morphogenesis
|
GO:0042471 |
118 |
0.083
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.083
|
|
|
|
cranial nerve structural organization
|
GO:0021604 |
13 |
0.083
|
|
|
|
bone morphogenesis
|
GO:0060349 |
78 |
0.083
|
|
|
|
calcium ion transport
|
GO:0006816 |
159 |
0.083
|
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
127 |
0.083
|
|
|
|
positive regulation of endocardial cushion to mesenchymal transition involved in heart valve formation
|
GO:2000802 |
1 |
0.083
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.082
|
|
|
|
parasympathetic nervous system development
|
GO:0048486 |
19 |
0.081
|
|
|
|
negative regulation of canonical wnt signaling pathway
|
GO:0090090 |
51 |
0.081
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.081
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.081
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.080
|
|
|
|
forebrain cell migration
|
GO:0021885 |
58 |
0.079
|
|
|
|
regulation of rho protein signal transduction
|
GO:0035023 |
71 |
0.079
|
|
|
|
negative regulation of cell projection organization
|
GO:0031345 |
56 |
0.077
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.077
|
|
|
|
cardiocyte differentiation
|
GO:0035051 |
87 |
0.077
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.076
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.076
|
|
|
|
tube closure
|
GO:0060606 |
91 |
0.076
|
|
|
|
regulation of cell size
|
GO:0008361 |
72 |
0.075
|
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
126 |
0.075
|
|
|
|
cell proliferation in hindbrain
|
GO:0021534 |
10 |
0.074
|
|
|
|
skeletal muscle fiber development
|
GO:0048741 |
58 |
0.074
|
|
|
|
positive regulation of cell migration
|
GO:0030335 |
109 |
0.074
|
|
|
|
regulation of extent of cell growth
|
GO:0061387 |
52 |
0.073
|
|
|
|
sensory system development
|
GO:0048880 |
3 |
0.073
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.073
|
|
|
|
response to drug
|
GO:0042493 |
75 |
0.073
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.073
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.073
|
|
|
|
cervix development
|
GO:0060067 |
2 |
0.072
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.072
|
|
|
|
cellular calcium ion homeostasis
|
GO:0006874 |
119 |
0.072
|
|
|
|
cellular response to abiotic stimulus
|
GO:0071214 |
56 |
0.071
|
|
|
|
regulation of bmp signaling pathway
|
GO:0030510 |
60 |
0.071
|
|
|
|
regulation of cartilage development
|
GO:0061035 |
44 |
0.071
|
|
|
|
sensory perception of pain
|
GO:0019233 |
47 |
0.070
|
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.070
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.070
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.070
|
|
|
|
b cell differentiation
|
GO:0030183 |
78 |
0.069
|
|
|
|
organic hydroxy compound biosynthetic process
|
GO:1901617 |
77 |
0.069
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.069
|
|
|
|
hippocampus development
|
GO:0021766 |
52 |
0.069
|
|
|
|
response to insulin
|
GO:0032868 |
100 |
0.069
|
|
|
|
regulation of calcium ion transport
|
GO:0051924 |
69 |
0.068
|
|
|
|
ear development
|
GO:0043583 |
200 |
0.068
|
|
|
|
regulation of glomerulus development
|
GO:0090192 |
6 |
0.067
|
|
|
|
leukocyte mediated immunity
|
GO:0002443 |
174 |
0.067
|
|
|
|
bone development
|
GO:0060348 |
120 |
0.067
|
|
|
|
cerebral cortex development
|
GO:0021987 |
86 |
0.067
|
|
|
|
glossopharyngeal nerve morphogenesis
|
GO:0021615 |
4 |
0.066
|
|
|
|
aortic valve morphogenesis
|
GO:0003180 |
4 |
0.066
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.066
|
|
|
|
mesenchyme development
|
GO:0060485 |
152 |
0.066
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.065
|
|
|
|
positive regulation of inner ear receptor cell differentiation
|
GO:2000982 |
1 |
0.065
|
|
|
|
detection of stimulus
|
GO:0051606 |
84 |
0.065
|
|
|
|
embryonic heart tube formation
|
GO:0003144 |
1 |
0.064
|
|
|
|
definitive hemopoiesis
|
GO:0060216 |
20 |
0.064
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.064
|
|
|
|
rhombomere formation
|
GO:0021594 |
1 |
0.063
|
|
|
|
gastrulation
|
GO:0007369 |
116 |
0.063
|
|
|
|
intestinal epithelial structure maintenance
|
GO:0060729 |
4 |
0.063
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.063
|
|
|
|
vascular process in circulatory system
|
GO:0003018 |
62 |
0.063
|
|
|
|
positive regulation of nucleoside metabolic process
|
GO:0045979 |
91 |
0.063
|
|
|
|
norepinephrine transport
|
GO:0015874 |
2 |
0.063
|
|
|
|
spinal cord motor neuron differentiation
|
GO:0021522 |
35 |
0.063
|
|
|
|
mesonephros development
|
GO:0001823 |
97 |
0.062
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.062
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.062
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.062
|
|
|
|
pericardium development
|
GO:0060039 |
16 |
0.062
|
|
|
|
preganglionic parasympathetic nervous system development
|
GO:0021783 |
17 |
0.061
|
|
|
|
central nervous system neuron development
|
GO:0021954 |
67 |
0.061
|
|
|
|
pancreatic pp cell fate commitment
|
GO:0003329 |
2 |
0.061
|
|
|
|
adult behavior
|
GO:0030534 |
135 |
0.061
|
|
|
|
cellular potassium ion transport
|
GO:0071804 |
43 |
0.061
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.060
|
|
|
|
positive regulation of leukocyte differentiation
|
GO:1902107 |
86 |
0.059
|
|
|
|
dorsal spinal cord development
|
GO:0021516 |
20 |
0.059
|
|
|
|
mesoderm morphogenesis
|
GO:0048332 |
64 |
0.059
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.059
|
|
|
|
embryonic skeletal system development
|
GO:0048706 |
120 |
0.059
|
|
|
|
spinal cord motor neuron cell fate specification
|
GO:0021520 |
13 |
0.059
|
|
|
|
peptide transport
|
GO:0015833 |
133 |
0.059
|
|
|
|
spinal cord association neuron differentiation
|
GO:0021527 |
14 |
0.059
|
|
|
|
positive regulation of ion transport
|
GO:0043270 |
65 |
0.058
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.058
|
|
|
|
prostate gland epithelium morphogenesis
|
GO:0060740 |
31 |
0.058
|
|
|
|
positive regulation of map kinase activity
|
GO:0043406 |
84 |
0.058
|
|
|
|
t cell differentiation in thymus
|
GO:0033077 |
77 |
0.058
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
128 |
0.058
|
|
|
|
sclerotome development
|
GO:0061056 |
4 |
0.057
|
|
|
|
cell proliferation involved in outflow tract morphogenesis
|
GO:0061325 |
4 |
0.057
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.057
|
|
|
|
cerebral cortex cell migration
|
GO:0021795 |
44 |
0.057
|
|
|
|
regulation of metanephros development
|
GO:0072215 |
15 |
0.057
|
|
|
|
regulation of b cell activation
|
GO:0050864 |
81 |
0.056
|
|
|
|
ventral spinal cord development
|
GO:0021517 |
48 |
0.056
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.056
|
|
|
|
regulation of protein secretion
|
GO:0050708 |
82 |
0.056
|
|
|
|
embryonic epithelial tube formation
|
GO:0001838 |
130 |
0.055
|
|
|
|
negative regulation of myeloid cell differentiation
|
GO:0045638 |
38 |
0.055
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.054
|
|
|
|
endodermal cell fate specification
|
GO:0001714 |
4 |
0.054
|
|
|
|
regulation of metal ion transport
|
GO:0010959 |
106 |
0.054
|
|
|
|
positive regulation of cell activation
|
GO:0050867 |
158 |
0.054
|
|
|
|
positive regulation of cell adhesion
|
GO:0045785 |
80 |
0.054
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.054
|
|
|
|
regulation of mesonephros development
|
GO:0061217 |
24 |
0.053
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.053
|
|
|
|
motor neuron axon guidance
|
GO:0008045 |
26 |
0.053
|
|
|
|
mesoderm formation
|
GO:0001707 |
62 |
0.053
|
|
|
|
positive regulation of phospholipase activity
|
GO:0010518 |
3 |
0.053
|
|
|
|
facial nerve structural organization
|
GO:0021612 |
10 |
0.052
|
|
|
|
nephron tubule morphogenesis
|
GO:0072078 |
68 |
0.052
|
|
|
|
sequestering of calcium ion
|
GO:0051208 |
18 |
0.052
|
|
|
|
cell division
|
GO:0051301 |
120 |
0.051
|
|
|
|
synaptic transmission involved in micturition
|
GO:0060084 |
3 |
0.051
|
|
|
|
neuron death
|
GO:0070997 |
154 |
0.051
|
|
|
|
myeloid cell homeostasis
|
GO:0002262 |
114 |
0.051
|
|
|
|
positive regulation of secretion
|
GO:0051047 |
130 |
0.051
|
|
|
|
trachea cartilage morphogenesis
|
GO:0060535 |
4 |
0.051
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.050
|
|
|
|
kidney morphogenesis
|
GO:0060993 |
83 |
0.050
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.050
|
|
|
|
cellular carbohydrate metabolic process
|
GO:0044262 |
119 |
0.050
|
|
|
|
positive regulation of mechanoreceptor differentiation
|
GO:0045633 |
1 |
0.050
|
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
130 |
0.050
|
|
|
|
glucose homeostasis
|
GO:0042593 |
128 |
0.050
|
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.049
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.049
|
|
|
|
muscle cell development
|
GO:0055001 |
133 |
0.049
|
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.049
|
|
|
|
semaphorin plexin signaling pathway involved in outflow tract morphogenesis
|
GO:0071527 |
1 |
0.049
|
|
|
|
mesenchymal to epithelial transition
|
GO:0060231 |
12 |
0.049
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.048
|
|
|
|
regulation of interferon gamma production
|
GO:0032649 |
57 |
0.048
|
|
|
|
somatotropin secreting cell differentiation
|
GO:0060126 |
4 |
0.047
|
|
|
|
auditory receptor cell fate determination
|
GO:0042668 |
3 |
0.047
|
|
|
|
dorsal ventral axon guidance
|
GO:0033563 |
3 |
0.047
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.047
|
|
|
|
regulation of morphogenesis of a branching structure
|
GO:0060688 |
53 |
0.047
|
|
|
|
hypophysis morphogenesis
|
GO:0048850 |
3 |
0.047
|
|
|
|
phenol containing compound biosynthetic process
|
GO:0046189 |
21 |
0.047
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.047
|
|
|
|
response to oxidative stress
|
GO:0006979 |
123 |
0.046
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.046
|
|
|
|
regulation of blood circulation
|
GO:1903522 |
93 |
0.046
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.046
|
|
|
|
rhombomere morphogenesis
|
GO:0021593 |
2 |
0.046
|
|
|
|
positive regulation of calcium ion transport
|
GO:0051928 |
27 |
0.046
|
|
|
|
cardiac neural crest cell migration involved in outflow tract morphogenesis
|
GO:0003253 |
3 |
0.046
|
|
|
|
positive regulation of neuroblast proliferation
|
GO:0002052 |
19 |
0.045
|
|
|
|
response to decreased oxygen levels
|
GO:0036293 |
59 |
0.045
|
|
|
|
hepaticobiliary system development
|
GO:0061008 |
67 |
0.045
|
|
|
|
sprouting angiogenesis
|
GO:0002040 |
26 |
0.045
|
|
|
|
positive regulation of mesonephros development
|
GO:0061213 |
20 |
0.045
|
|
|
|
facial nerve morphogenesis
|
GO:0021610 |
11 |
0.045
|
|
|
|
stem cell maintenance
|
GO:0019827 |
130 |
0.045
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.045
|
|
|
|
peptidyl serine phosphorylation
|
GO:0018105 |
74 |
0.045
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.045
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.045
|
|
|
|
regulation of action potential
|
GO:0098900 |
4 |
0.045
|
|
|
|
positive regulation of protein serine threonine kinase activity
|
GO:0071902 |
106 |
0.044
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.044
|
|
|
|
mammary gland epithelium development
|
GO:0061180 |
65 |
0.044
|
|
|
|
regulation of heart growth
|
GO:0060420 |
31 |
0.044
|
|
|
|
respiratory gaseous exchange
|
GO:0007585 |
43 |
0.044
|
|
|
|
regulation of metanephric glomerulus development
|
GO:0072298 |
5 |
0.044
|
|
|
|
odontogenesis
|
GO:0042476 |
78 |
0.044
|
|
|
|
blood vessel endothelial cell migration
|
GO:0043534 |
23 |
0.044
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.044
|
|
|
|
female gonad development
|
GO:0008585 |
71 |
0.043
|
|
|
|
positive regulation of chemotaxis
|
GO:0050921 |
38 |
0.043
|
|
|
|
negative regulation of neuron differentiation
|
GO:0045665 |
101 |
0.043
|
|
|
|
bronchiole development
|
GO:0060435 |
3 |
0.043
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.043
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.043
|
|
|
|
regulation of branching involved in ureteric bud morphogenesis
|
GO:0090189 |
22 |
0.043
|
|
|
|
retina development in camera type eye
|
GO:0060041 |
119 |
0.043
|
|
|
|
neural tube formation
|
GO:0001841 |
108 |
0.043
|
|
|
|
carbohydrate homeostasis
|
GO:0033500 |
128 |
0.043
|
|
|
|
regulation of neuroblast proliferation
|
GO:1902692 |
27 |
0.043
|
|
|
|
heart growth
|
GO:0060419 |
45 |
0.043
|
|
|
|
negative regulation of kinase activity
|
GO:0033673 |
81 |
0.043
|
|
|
|
calcium ion transport into cytosol
|
GO:0060402 |
48 |
0.043
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.042
|
|
|
|
ureteric bud development
|
GO:0001657 |
94 |
0.042
|
|
|
|
pancreatic a cell fate commitment
|
GO:0003326 |
2 |
0.042
|
|
|
|
formation of organ boundary
|
GO:0010160 |
1 |
0.042
|
|
|
|
neural tube closure
|
GO:0001843 |
90 |
0.042
|
|
|
|
positive regulation of ion transmembrane transport
|
GO:0034767 |
24 |
0.042
|
|
|
|
negative regulation of transferase activity
|
GO:0051348 |
85 |
0.042
|
|
|
|
regulation of lymphocyte differentiation
|
GO:0045619 |
107 |
0.042
|
|
|
|
positive regulation of dopamine secretion
|
GO:0033603 |
2 |
0.042
|
|
|
|
pigmentation
|
GO:0043473 |
71 |
0.041
|
|
|
|
formation of primary germ layer
|
GO:0001704 |
77 |
0.041
|
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
132 |
0.041
|
|
|
|
negative regulation of cell morphogenesis involved in differentiation
|
GO:0010771 |
48 |
0.041
|
|
|
|
guanosine containing compound metabolic process
|
GO:1901068 |
144 |
0.041
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.041
|
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
130 |
0.041
|
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
174 |
0.041
|
|
|
|
endomembrane system organization
|
GO:0010256 |
147 |
0.041
|
|
|
|
regulation of cell growth
|
GO:0001558 |
91 |
0.041
|
|
|
|
positive regulation of heart growth
|
GO:0060421 |
18 |
0.041
|
|
|
|
neural crest cell differentiation
|
GO:0014033 |
54 |
0.041
|
|
|
|
neuromuscular process
|
GO:0050905 |
99 |
0.041
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.040
|
|
|
|
single organismal cell cell adhesion
|
GO:0016337 |
131 |
0.040
|
|
|
|
branchiomeric skeletal muscle development
|
GO:0014707 |
3 |
0.040
|
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
106 |
0.040
|
|
|
|
biomineral tissue development
|
GO:0031214 |
64 |
0.040
|
|
|
|
lymphocyte proliferation
|
GO:0046651 |
164 |
0.040
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.040
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.040
|
|
|
|
renal sodium excretion
|
GO:0035812 |
3 |
0.039
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.039
|
|
|
|
release of sequestered calcium ion into cytosol
|
GO:0051209 |
42 |
0.039
|
|
|
|
cognition
|
GO:0050890 |
149 |
0.039
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.039
|
|
|
|
positive regulation of hormone secretion
|
GO:0046887 |
38 |
0.039
|
|
|
|
regulation of reproductive process
|
GO:2000241 |
66 |
0.039
|
|
|
|
negative regulation of synapse assembly
|
GO:0051964 |
3 |
0.038
|
|
|
|
developmental pigmentation
|
GO:0048066 |
40 |
0.038
|
|
|
|
salivary gland morphogenesis
|
GO:0007435 |
33 |
0.038
|
|
|
|
regulation of jnk cascade
|
GO:0046328 |
62 |
0.038
|
|
|
|
embryonic placenta development
|
GO:0001892 |
98 |
0.038
|
|
|
|
kidney vasculature development
|
GO:0061440 |
15 |
0.038
|
|
|
|
regulation of stem cell proliferation
|
GO:0072091 |
78 |
0.038
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.038
|
|
|
|
positive regulation of semaphorin plexin signaling pathway involved in outflow tract morphogenesis
|
GO:2000764 |
1 |
0.038
|
|
|
|
regulation of gtp catabolic process
|
GO:0033124 |
113 |
0.038
|
|
|
|
cerebellar granule cell precursor proliferation
|
GO:0021930 |
10 |
0.037
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.037
|
|
|
|
myotube cell development
|
GO:0014904 |
60 |
0.037
|
|
|
|
limb development
|
GO:0060173 |
166 |
0.037
|
|
|
|
response to hypoxia
|
GO:0001666 |
58 |
0.037
|
|
|
|
peptidyl serine modification
|
GO:0018209 |
83 |
0.037
|
|
|
|
regulation of rho gtpase activity
|
GO:0032319 |
58 |
0.037
|
|
